Zolgensma suspension for intravenous infusion Images
Generic Name: onasemnogene abeparvovec
This medication has been identified as Zolgensma suspension for intravenous infusion. It is supplied by Novartis Gene Therapies, Inc.
Zolgensma is used in the treatment of Spinal Muscular Atrophy and belongs to the drug class miscellaneous uncategorized agents. Zolgensma suspension for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Zolgensma
- Generic Name
- onasemnogene abeparvovec
- Strength
- suspension for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Miscellaneous uncategorized agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Gene Therapies, Inc.
- National Drug Code (NDC)
More about Zolgensma (onasemnogene abeparvovec)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.